These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 3661548)
1. Effects of a magnesium-free dialysate on magnesium metabolism during continuous ambulatory peritoneal dialysis. Shah GM; Winer RL; Cutler RE; Arieff AI; Goodman WG; Lacher JW; Schoenfeld PY; Coburn JW; Horowitz AM Am J Kidney Dis; 1987 Oct; 10(4):268-75. PubMed ID: 3661548 [TBL] [Abstract][Full Text] [Related]
2. Use of magnesium hydroxide and low magnesium dialysate does not permit reduction of aluminum hydroxide during continuous ambulatory peritoneal dialysis. Jennings AE; Bodvarsson M; Galicka-Piskorska G; Diefendorf AS; Simon GM; Levey AS Am J Kidney Dis; 1986 Sep; 8(3):192-5. PubMed ID: 3752074 [TBL] [Abstract][Full Text] [Related]
3. Relationship between the serum parathyroid hormone and magnesium levels in continuous ambulatory peritoneal dialysis (CAPD) patients using low-magnesium peritoneal dialysate. Cho MS; Lee KS; Lee YK; Ma SK; Ko JH; Kim SW; Kim NH; Choi KC Korean J Intern Med; 2002 Jun; 17(2):114-21. PubMed ID: 12164088 [TBL] [Abstract][Full Text] [Related]
4. Low dialysate calcium in continuous ambulatory peritoneal dialysis: a randomized controlled multicenter trial. The Peritoneal Dialysis Multicenter Study Group. Weinreich T; Passlick-Deetjen J; Ritz E Am J Kidney Dis; 1995 Mar; 25(3):452-60. PubMed ID: 7872324 [TBL] [Abstract][Full Text] [Related]
5. The use of magnesium-containing phosphate binders in patients with end-stage renal disease on maintenance hemodialysis. Guillot AP; Hood VL; Runge CF; Gennari FJ Nephron; 1982; 30(2):114-7. PubMed ID: 7099318 [TBL] [Abstract][Full Text] [Related]